These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 327552)
21. Clinical test methods for antitumor drugs in the U.S.S.R. Garin AM; Lichinitser MR Natl Cancer Inst Monogr; 1977 Mar; (45):227-33. PubMed ID: 337153 [No Abstract] [Full Text] [Related]
22. [Problems of the modern chemotherapy of tumors]. Garin AM; Perevoschikova NI Vestn Akad Med Nauk SSSR; 1982; (12):55-60. PubMed ID: 7157992 [No Abstract] [Full Text] [Related]
23. We fought cancer...and cancer won. Begley S Newsweek; 2008 Sep; 152(11):42-4, 46, 57-8 passim. PubMed ID: 18800570 [No Abstract] [Full Text] [Related]
24. [History of cancer and chemotherapy before chemotherapy]. Bonnichon P; Berger JP; Bonni N; Fontaine M; Pion-Graff J Hist Sci Med; 2014; 48(4):469-74. PubMed ID: 25962214 [TBL] [Abstract][Full Text] [Related]
25. Navelbine: a new step in cancer therapy? Armand JP; Marty M Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319 [No Abstract] [Full Text] [Related]
26. A review of clinical studies on aclacinomycin A--phase I and preliminary phase II evaluation of ACM. Oka S Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):37-49. PubMed ID: 572582 [No Abstract] [Full Text] [Related]
27. Thoughts on cancer chemotherapy and combination modality therapy (1974). Skipper HE JAMA; 1974 Nov; 230(7):1033-5. PubMed ID: 4608173 [No Abstract] [Full Text] [Related]
29. Historical development and future promise of the nitrosoureas as anticancer agents. Schabel FM Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035 [No Abstract] [Full Text] [Related]
30. Clinical development of anticancer agents--a National Cancer Institute perspective. Marsoni S; Wittes R Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870 [No Abstract] [Full Text] [Related]
32. [Transferability of animal experiment results to cytostatic chemotherapy on humans]. Karrer K Adv Clin Pharmacol; 1977; 14():89-97. PubMed ID: 596276 [No Abstract] [Full Text] [Related]
33. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Poste G Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734 [TBL] [Abstract][Full Text] [Related]
34. [Contribution to the treatment of patients with cancer in the 18th century (author's transl)]. Gottlieb J Folia Clin Int (Barc); 1975 Nov; 25(11):613-7. PubMed ID: 767168 [No Abstract] [Full Text] [Related]
35. [Combination chemotherapy and radiotherapy in the treatment of malignant tumors: indications and hazards]. Bartelink H; Somers R Ned Tijdschr Geneeskd; 1980 Apr; 124(15):564-8. PubMed ID: 7374818 [No Abstract] [Full Text] [Related]
36. Combination chemotherapy: considerations for design and analysis. Lloyd HH Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495 [No Abstract] [Full Text] [Related]
37. [The problems of combining chemotherapy and radiotherapy]. Tanaka Y; Hasegawa T; Akagi K; Kato T Gan No Rinsho; 1987 Oct; 33(13):1664-72. PubMed ID: 3694800 [TBL] [Abstract][Full Text] [Related]
38. Combination therapy: some concepts and results. Skipper HE Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649 [No Abstract] [Full Text] [Related]
39. Cancer chemotherapy in historical perspective. Kardinal CG J La State Med Soc; 1993 Apr; 145(4):175-7. PubMed ID: 8486991 [TBL] [Abstract][Full Text] [Related]
40. Screening at the National Cancer Institute. Goldin A; Venditti JM; Carter SK Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]